Pages that link to "Q27001052"
Jump to navigation
Jump to search
The following pages link to NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma (Q27001052):
Displaying 50 items.
- Role of Tim-3 in hepatitis B virus infection: An overview (Q26768530) (← links)
- Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity (Q26773135) (← links)
- Liver natural killer cells: subsets and roles in liver immunity (Q26774237) (← links)
- The Role of Immune Cells in Chronic HBV Infection (Q26774875) (← links)
- Cellular and molecular regulation of innate inflammatory responses (Q28079497) (← links)
- Natural killer cell activation contributes to hepatitis B viral control in a mouse model (Q33670723) (← links)
- The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases (Q33790954) (← links)
- Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation (Q35751024) (← links)
- The predictive value of centre tumour CD8⁺ T cells in patients with hepatocellular carcinoma: comparison with Immunoscore (Q36546411) (← links)
- HBV suppresses expression of MICA/B on hepatoma cells through up-regulation of transcription factors GATA2 and GATA3 to escape from NK cell surveillance (Q37636590) (← links)
- Pivotal roles of ILCs in hepatic diseases (Q38366661) (← links)
- Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection. (Q38668279) (← links)
- Immune balance in Hepatitis B Infection: Present and Future Therapies (Q38733622) (← links)
- NK cell education via nonclassical MHC and non-MHC ligands (Q38855657) (← links)
- Tissue-resident natural killer cells in the livers (Q39026625) (← links)
- Respiratory Influenza Virus Infection Induces Memory-like Liver NK Cells in Mice. (Q39056753) (← links)
- Siglec-7 Defines a Highly Functional Natural Killer Cell Subset and Inhibits Cell-Mediated Activities (Q39677106) (← links)
- Developmental and Functional Control of Natural Killer Cells by Cytokines (Q40086298) (← links)
- Increased levels of soluble HLA-G molecules in Tunisian patients with chronic hepatitis B infection (Q40233245) (← links)
- High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer (Q40333142) (← links)
- Liver-infiltrating CD11b(-)CD27(-) NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression (Q40692653) (← links)
- Programmed differentiated natural killer cells kill leukemia cells by engaging SLAM family receptors. (Q41343418) (← links)
- "Multi-Omics" Analyses of the Development and Function of Natural Killer Cells (Q41453369) (← links)
- Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes (Q41664041) (← links)
- Natural Killer Cell Memory: Progress and Implications (Q41684068) (← links)
- Lower Expression of MicroRNA-155 Contributes to Dysfunction of Natural Killer Cells in Patients with Chronic Hepatitis B (Q41919609) (← links)
- CMI: Highlights in last three years (Q42390982) (← links)
- Association of decreased expression of the macrophage scavenger receptor MARCO with tumor progression and poor prognosis in human hepatocellular carcinoma (Q42774837) (← links)
- Overview of the special issue on HBV immunity (Q43162216) (← links)
- Suppression of Natural Killer Cell Activity by Regulatory NKT10 Cells Aggravates Alcoholic Hepatosteatosis (Q46059784) (← links)
- Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy (Q47843897) (← links)
- Liver-resident NK cells and their potential functions (Q50049018) (← links)
- Natural killer cells in liver diseases. (Q52314600) (← links)
- MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer. (Q52595263) (← links)
- Tumor immunotherapy: New aspects of natural killer cells. (Q55107050) (← links)
- Ambiguous roles of innate lymphoid cells in chronic development of liver diseases. (Q55208795) (← links)
- Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication. (Q55259976) (← links)
- Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections (Q58091387) (← links)
- Human CD96 correlates to NK cell exhaustion and predicts the prognosis of human hepatocellular carcinoma (Q58580678) (← links)
- Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update (Q59329484) (← links)
- miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3 (Q61796205) (← links)
- High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway (Q64056215) (← links)
- γδT Cells Suppress Liver Fibrosis via Strong Cytolysis and Enhanced NK Cell-Mediated Cytotoxicity Against Hepatic Stellate Cells (Q64086732) (← links)
- From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma (Q89998270) (← links)
- Targeting Natural Killer Cells for Tumor Immunotherapy (Q90093145) (← links)
- Hepatocellular carcinoma: Mechanisms of progression and immunotherapy (Q92104140) (← links)
- CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy (Q92853203) (← links)
- Warm up, cool down, and tearing apart in NK cell memory (Q93381990) (← links)
- Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma (Q96348711) (← links)
- Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy (Q97883506) (← links)